C57BL/6JCya-Eif1aem1/Cya
Common Name
Eif1a-KO
Product ID
S-KO-01855
Backgroud
C57BL/6JCya
Strain ID
KOCMP-13664-Eif1a-B6J-VA
Status
When using this mouse strain in a publication, please cite “Eif1a-KO Mouse (Catalog S-KO-01855) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
Basic Information
Strain Name
Eif1a-KO
Strain ID
KOCMP-13664-Eif1a-B6J-VA
Gene Name
Product ID
S-KO-01855
Gene Alias
Ef1a, Eftu, Eif4c, eIF-1A, eIF-4C
Background
C57BL/6JCya
Gene Full Name
eukaryotic translation initiation factor 1A
Modification
Conventional knockout
NCBI ID
Phenotype
Chromosome
Chr 18 (Mouse)
Application
--
Datasheet
Strain Description
Ensembl Transcript ID
ENSMUST00000237478
NCBI Transcript ID
NM_001374654
Target Region
Exon 3
Size of Effective Region
~0.6 kb
Overview of Gene Research
Eif1a, eukaryotic translation initiation factor 1A, is a highly conserved gene encoding a translation initiation factor in eukaryotes. It plays multiple crucial roles in translation initiation, including the assembly of ribosomal pre-initiation complexes, mRNA binding, scanning, and ribosomal subunit joining. It interacts with several other translation initiation factors, such as eIF5B, eIF5, and Ago2, and is involved in pathways like miRNA biogenesis and RNA interference [2,3,4,5].
In human pituitary adenoma (PA) research, knockdown of Eif1a via lentivirus-mediated construction of knockdown cell models revealed that its depletion seriously limits cell proliferation, weakens cell migration capacity, and enhances tumor cell apoptosis. Mechanistically, this may involve activation of the MAPK signaling pathway and inactivation of the PI3K/AKT signaling pathway [1].
In conclusion, Eif1a is essential for translation-related biological processes. Its study through gene-knockdown models has revealed its role in promoting tumor cell proliferation and migration in pituitary adenoma, providing insights into the disease mechanism and potential therapeutic targets.
References:
1. Geng, Rongxin, Zhu, Xiaonan, Tao, Xiang, Liu, Junhui, Xu, Haitao. 2021. EIF1A depletion restrains human pituitary adenoma progression. In Translational oncology, 15, 101299. doi:10.1016/j.tranon.2021.101299. https://pubmed.ncbi.nlm.nih.gov/34864402/
2. Yi, Tingfang, Arthanari, Haribabu, Akabayov, Barak, Huang, Stephen A, Wagner, Gerhard. 2015. eIF1A augments Ago2-mediated Dicer-independent miRNA biogenesis and RNA interference. In Nature communications, 6, 7194. doi:10.1038/ncomms8194. https://pubmed.ncbi.nlm.nih.gov/26018492/
3. Nag, Nabanita, Lin, Kai Ying, Edmonds, Katherine A, Marintcheva, Boriana, Marintchev, Assen. 2016. eIF1A/eIF5B interaction network and its functions in translation initiation complex assembly and remodeling. In Nucleic acids research, 44, 7441-56. doi:10.1093/nar/gkw552. https://pubmed.ncbi.nlm.nih.gov/27325746/
4. Gamble, Nathan, Paul, Eleanor Elise, Anand, Bibin, Marintchev, Assen. 2022. Regulation of the interactions between human eIF5 and eIF1A by the CK2 kinase. In Current research in structural biology, 4, 308-319. doi:10.1016/j.crstbi.2022.09.003. https://pubmed.ncbi.nlm.nih.gov/36164648/
5. Lin, Kai Ying, Nag, Nabanita, Pestova, Tatyana V, Marintchev, Assen. 2018. Human eIF5 and eIF1A Compete for Binding to eIF5B. In Biochemistry, 57, 5910-5920. doi:10.1021/acs.biochem.8b00839. https://pubmed.ncbi.nlm.nih.gov/30211544/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
